No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Fosrenol is a phosphate binder used to treat hyperphosphatemia in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). It is also used to treat hyperphosphatemia in patients with liver disorders, such as primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). Fosrenol works by binding to dietary phosphate in the gastrointestinal tract, preventing its absorption and reducing serum phosphate levels.
Fosrenol is part of a larger market of drugs used to treat liver and kidney disorders. These drugs include diuretics, ACE inhibitors, angiotensin receptor blockers, and other phosphate binders. The market for these drugs is driven by the increasing prevalence of chronic kidney and liver diseases, as well as the need for effective treatments.
Companies in the Fosrenol market include Shire, Daiichi Sankyo, and Novartis. Show Less Read more
